Patents Assigned to Tolerion, Inc.
  • Publication number: 20190315827
    Abstract: The present invention provides compositions and methods for treating insulin-dependent diabetes mellitus in a subject comprising administration of a self-vector encoding and expressing human proinsulin.
    Type: Application
    Filed: November 21, 2018
    Publication date: October 17, 2019
    Applicant: Tolerion, Inc.
    Inventors: Bart O. Roep, William H. Robinson, Paul Utz, Hideki Garren, Lawrence Steinman